scispace - formally typeset
P

Paramita Bhattacharya

Researcher at Indian Statistical Institute

Publications -  18
Citations -  491

Paramita Bhattacharya is an academic researcher from Indian Statistical Institute. The author has contributed to research in topics: Population & Cervical cancer. The author has an hindex of 10, co-authored 14 publications receiving 459 citations. Previous affiliations of Paramita Bhattacharya include Saha Institute of Nuclear Physics.

Papers
More filters
Journal ArticleDOI

CpG methylation of half-CRE sequences creates C/EBPα binding sites that activate some tissue-specific genes

TL;DR: It is shown that CpG methylation of the CRE sequence (TGACGTCA) enhances the DNA binding of the C/EBPα transcription factor, a protein critical for activation of differentiation in various cell types.
Journal ArticleDOI

A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India

TL;DR: Women from northeast India, particularly from Manipur, appear less susceptible to HPV16/18 infection and related cervical lesions compared to those from West Bengal, where such proneness was prominently evident at age ≤30 years.
Journal ArticleDOI

Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women

TL;DR: Prolinehomozygosity at codon 72 of p53 and not arginine homozygosity, could be a risk factor for development of CaCx associated with high risk HPV among Indian women.
Journal ArticleDOI

Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India.

TL;DR: The data show that these Indian Muslim women are equally susceptible to HPV16/18 infection and for the development of abnormal cytology, which justifies the need to screen women of all religions for cervical cancer.
Journal ArticleDOI

Oncogenic human papillomavirus (HPV) infection and uterine cervical cancer: a screening strategy in the perspective of rural India

TL;DR: A cost-effective screening scheme in which HPV testing must be performed in women aged ≤23 years with cervical erosion and 24–43 years, as an adjunct to Pap smears is proposed, since abnormal cytology was more prominent over the viral infection.